Premium
IC‐P‐084: Use of an fdg‐pet‐derived hypometabolic convergence index enrichment strategy to reduce sample sizes in alzheimer's disease clinical trials: Findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Author(s) -
Ayutyat Napatkamon,
Chen Kewei,
Roontiva Auttawut,
Fleisher Adam,
Langbaum Jessica,
Reschke Cole,
Lee Wendy,
Liu Xiaofen,
Bandy Dan,
Alexander Gene,
Foster Norman,
Harvey Danielle,
Weiner Michael,
Koeppe Robert,
Jagust William,
Reiman Eric
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.150
Subject(s) - clinical dementia rating , neuroimaging , dementia , cognitive decline , alzheimer's disease neuroimaging initiative , clinical trial , cognition , positron emission tomography , disease , alzheimer's disease , medicine , audiology , psychology , nuclear medicine , psychiatry